Bias and Confounding in Studies of Chronic Mental Health Effects from Mefloquine Exposure.
作者信息
Nevin Remington Lee
机构信息
The Quinism Foundation.
出版信息
Am J Trop Med Hyg. 2019 Feb;100(2):476-477. doi: 10.4269/ajtmh.18-0771a.
Abstract
摘要
相似文献
1
Bias and Confounding in Studies of Chronic Mental Health Effects from Mefloquine Exposure.
Am J Trop Med Hyg. 2019 Feb;100(2):476-477. doi: 10.4269/ajtmh.18-0771a.
2
Associations between Use of Antimalarial Medications and Health among U.S. Veterans of the Wars in Iraq and Afghanistan.
Am J Trop Med Hyg. 2018 Sep;99(3):638-648. doi: 10.4269/ajtmh.18-0107. Epub 2018 Jun 21.
3
Threats to the validity of studies of post-traumatic stress disorder from unmeasured symptomatic exposure to mefloquine.
Br J Psychiatry. 2019 Apr;214(4):237. doi: 10.1192/bjp.2019.1.
4
Getting beyond "Don't ask; don't tell": an evaluation of US Veterans Administration postdeployment mental health screening of veterans returning from Iraq and Afghanistan.
Am J Public Health. 2008 Apr;98(4):714-20. doi: 10.2105/AJPH.2007.115519. Epub 2008 Feb 28.
5
Mental health diagnoses and utilization of VA non-mental health medical services among returning Iraq and Afghanistan veterans.
J Gen Intern Med. 2010 Jan;25(1):18-24. doi: 10.1007/s11606-009-1117-3. Epub 2009 Sep 29.
6
Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008.
Am J Public Health. 2009 Sep;99(9):1651-8. doi: 10.2105/AJPH.2008.150284. Epub 2009 Jul 16.
7
8
Race/ethnicity and gender differences in mental health diagnoses among Iraq and Afghanistan veterans.
Psychiatry Res. 2015 Oct 30;229(3):724-31. doi: 10.1016/j.psychres.2015.08.013. Epub 2015 Aug 10.
9
Eating disorders and psychiatric comorbidity among Iraq and Afghanistan veterans.
Womens Health Issues. 2012 Jul-Aug;22(4):e403-6. doi: 10.1016/j.whi.2012.04.005.
10
Symptom Severity, Self-efficacy and Treatment-Seeking for Mental Health Among US Iraq/Afghanistan Military Veterans.
Community Ment Health J. 2020 Oct;56(7):1239-1247. doi: 10.1007/s10597-020-00578-8. Epub 2020 Feb 17.
引用本文的文献
1
In Response to the Letter by Nevin.
Am J Trop Med Hyg. 2019 Feb;100(2):478-479. doi: 10.4269/ajtmh.18-0771b.
本文引用的文献
1
Screening for Symptomatic Mefloquine Exposure Among Veterans With Chronic Psychiatric Symptoms.
Fed Pract. 2017 Mar;34(3):12-14.
2
Associations between Use of Antimalarial Medications and Health among U.S. Veterans of the Wars in Iraq and Afghanistan.
Am J Trop Med Hyg. 2018 Sep;99(3):638-648. doi: 10.4269/ajtmh.18-0107. Epub 2018 Jun 21.
3
RE: "A DECADE OF WAR: PROSPECTIVE TRAJECTORIES OF POSTTRAUMATIC STRESS DISORDER SYMPTOMS AMONG DEPLOYED US MILITARY PERSONNEL AND THE INFLUENCE OF COMBAT EXPOSURE".
Am J Epidemiol. 2018 Jul 1;187(7):1573-1574. doi: 10.1093/aje/kwy072.
4
Mefloquine for preventing malaria during travel to endemic areas.
Cochrane Database Syst Rev. 2017 Oct 30;10(10):CD006491. doi: 10.1002/14651858.CD006491.pub4.
5
A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions.
Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.328.
6
Misclassification and Bias in Military Studies of Mefloquine.
Am J Trop Med Hyg. 2017 Jul;97(1):305. doi: 10.4269/ajtmh.17-0246.
7
Prolonged Neuropsychiatric Symptoms in a Military Service Member Exposed to Mefloquine.
Drug Saf Case Rep. 2016 Dec;3(1):7. doi: 10.1007/s40800-016-0030-z.
8
Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada.
Neurol Ther. 2016 Jun;5(1):69-83. doi: 10.1007/s40120-016-0045-5. Epub 2016 May 30.
Zotero 插件